Recently, remarkable microtubule inhibitor and anti-tumor activities of the bis(bibenzyl) marchantin C -isolated from liverworts like Marchantia polymorpha since 1983 -were found. In this paper we describe the efficient total synthesis of this subtype of bis(bibenzylic) compounds with two biarylether connections. Two selectively methylated derivatives known as natural compounds marchantin O and P were synthesized for the first time by modification of the arene subunits and can now be considered as promising highly bioactive compounds.
Bis(bibenzyls) are acyclic or cyclic phenolic natural products that are found exclusively in bryophytes [1] . Regarding the biosynthesis, they originate from two units of the bibenzyl precursor lunularic acid (1) , which can be combined by several modes of O-C and/or C-C attachment on the basis of phenol oxidation coupling to different subtypes (Scheme 1) [2] .
From the acyclic precursors perrottetin E (2) with O-C connection and isoperrottetin A (3) with C-C connection, respectively, are derived cyclic bis(bibenzyls) of the plagiochin/riccardin type like plagiochin E (4), the marchantin type like marchantin C (5) or the isoplagiochin type like isoplagiochin D (6) by a second O-C or C-C connection. Not all possible subtypes were isolated yet from bryophytes, for an overview see Ref. [3] . In the marchantin series, six subtypes are possible by the second O-C connection (Figure 1 ). Furthermore, derivatives containing additional hydroxyl or methyl ether functionalities were also isolated in many cases or the parent compound itself was not yet found. The "nomenclature" for these compounds is mainly deduced from the plant source and chronological aspects.
Marchantin C (5) represents the 3-O 2'-C cyclization type of 2 with no further modification and was first isolated from Marchantia polymorpha, Marchantia paleacea var. diterpa and Marchantia tosana [4] and then from additional six different liverwort species [5] [6] [7] . Its monomethylethers were isolated as marchantin O (7) [8, 9] and P (8) [10] , the dimethylether 9, however, was not yet found.
The following moderate biological activities were previously reported for marchantin C (5): cytotoxic activity against KB cell lines, anti-HIV-1 activity and DNA polymerase β inhibition [3, 11] , cytotoxicity in the P388 assay and some antimicrobial activity against the Gram-positive bacterium Bacillus subtilis and against Trichophyton mentagrophyte [12] , inhibition of lipopolysaccharide-induced nitric oxide synthase (NOS) in RAW 264.7 macrophages [13] and α-glucosidase inhibitory activity [7] .
But more recently, macrocyclic bis(bibenzyls) especially of the plagiochin/riccardin type and of the marchantin type are attracting an enhanced attention due to new significant biological activities [14] [15] [16] . Among these, marchantin C (5) induces apoptosis of human glioma A 172 cells [17] and proved to be a novel microtubule inhibitor with anti-tumor activity both in vivo and in vitro [18] . Furthermore, 5 and some derivatives were shown to sensitize vincristine-resistant KB/VCR cells to chemotherapeutic agents by retarding P-gp activity [19] . Surprisingly and for a long time, only material from natural sources was used for testing and marchantin C (5) , in contrast to other marchantin subtypes [20] [21] [22] , was not synthesized. Recently, we reported on an efficient synthesis for 5 and its dimethylether 9 [23] followed by a somewhat different strategy by Lou et al. [19] . Now, we report on a flexible route not only for 5 but also on individual routes for its monomethyl ethers marchantin O (7) and P (8) which are natural compounds as well. The selective introduction of a free hydroxyl groups should give raise not only for further derivatization but also to a deeper insight in the influence of the phenolic OH groups on the biological activities of 5 and its derivatives.
The "a-b-c-d" arene skeleton of marchantin C (5) was constructed as follows:
The 1,2,3-trisubstituted segment "b" was prepared as phosphonium salt 18 starting from o-vanillin (15) with O-benzylation followed by reduction and was reacted (Wittig procedure/hydrogenation) with the "c-a" fragment 19 [24] to the bibenzyl 20. The free phenolic hydroxyl group was coupled (Ullmann reaction) with 3-bromo benzaldehyde (21) yielding the acyclic precursor 23. After deprotection of the second aldehyde functionality (to 23), the dialdehyde was ring closed under McMurry conditions to give the stilbene 24. Finally, the bis(bibenzylic) macrocycle was obtained by hydrogenation to marchantin C dimethylether (9) and deprotection of the phenolic OH groups yielded compound 5 in 22% overall yield (five steps from 18 and 19, Scheme 2).
The spectroscopic data [23] match with those reported in the literature [25] for the isolated marchantin C (5). To exclude any errors in arene connection and substitution pattern, the structure of 5 was strongly verified by further NMR experiments (H,H COSY, C,H COSY, HMBC, see Tables 1 and 2). A modified "c-a" segment 29 was prepared from 3,4-dihydroxybenzaldehyde (25) (after selective protection via 26/27) and 4-fluorobenzaldehyde (28). Two-step transformation to the phosphonium salt 31 and Wittig reaction with o-vanillin (15) yielded the "c-a-b"-stilbene 32. Ullmann reaction with 21 as "d" moiety followed by acidic workup to the dialdehyde 33 and McMurry ring closure resulted in the macrocyclic bis(stilbene) 34, only the E,E isomer was isolated by crystallization. Finally, one-step hydrogenation yielded marchantin O (7) in 22% overall yield (9 steps from 25, Scheme 3). The spectroscopic data match with those reported in the literature [8] for the isolated compound (see Tables 1  and 2 ). The "a-b-c-d" arene skeleton of 12-methylated derivative marchantin P (8) was constructed as follows:
A modified "b" segment 36 was prepared selectively from 2,3-dihydroxybenzaldehyde (35) and coupled (Wittig reaction) to 38 with the phosphonium salt 37 obtained from the "c-a" fragment 19 [24] . Again, the "d" unit was introduced by Ullmann reaction with 21. 
2-(4-(5-(1,3-Dioxan-2-yl)-2-methoxyphenoxy)phenethyl)-6-methoxyphenol (20):
A mixture of the aldehyde 19 (5.66 g, 18.0 mmol), the phosphonium salt 18 (15.3 g, 27.0 mmol), K 2 CO 3 (4.98 g, 36.0 mmol) and a catalytic amount of 18-crown-6 in anhydrous CH 2 Cl 2 (250 mL) was heated under reflux for 24 h. After cooling to r.t. the mixture was filtered through a thin pad of SiO 2 , eluting with n-hexane / EtOAc (1:1) and concentrated. The crude stilbene was dissolved in EtOAc (300 mL) and NEt 3 (5 mL). After addition of Pd/C (5%) (500 mg) the mixture was hydrogenated in a Parr apparatus at 3 bar H 2 for 24 h. The catalyst was filtered off and the solvent was removed in vacuum. The crude material was purified by flash chromatography (SiO 2 , n-hexane/EtOAc 1:1). The bibenzyl 20 (4.79 g, 61%) was obtained as a colourless oil. 1 
3-(2-(4-(5-(1,3-Dioxan-2-yl)-2-methoxyphenoxy)phenethyl)-6-methoxyphenoxy)-benzaldehyde (22):
To a solution of the phenol 20 (4.00 g, 7.62 mmol) in anhydrous pyridine (100 mL) K 2 CO 3 (4.21 g, 30.5 mmol), CuO (3.28 g, 22.9 mmol) and 3-bromobenzaldehyde (21) (2.68 mL, 22.9 mmol) were added. The resulting reaction mixture was heated to 160°C for 12 h and the solvent was evaporated under reduced pressure. After dilution with CH 2 Cl 2 , the residue was filtered through a thin pad of SiO 2 eluting with CH 2 Cl 2 and the solvent was removed in vacuum. Purification of the crude product was achieved by flash chromatography (SiO 2 , n-hexane/EtOAc 3:7) to get the bis(diarylether) 22 (4.00 g, 97%) as a colourless resin. 
3-(4-(2-(3-Formylphenoxy)-3-methoxyphenethyl)phenoxy)-4-methoxybenzaldehyde (23):
The dioxane 22 (4.00 g, 7.40 mmol) was dissolved in THF (75 mL) and 2 M HCl (75 mL). After stirring for 12 h at r.t. the mixture was extracted with Et 2 O (3 × 150 mL), the combined organic layers were washed with satd NaHCO 3 and dried (MgSO 4 ). The solvent was removed under reduced pressure yielding the dialdehyde 23 (3.45 g, 97 %) as colourless, highly viscous oil. 1 
Marchantin C dimethylether (9):
The stilbene 24 (500 mg, 1.11 mmol) was dissolved in EtOAc (150 mL). After addition of Pd/C (5%) (100 mg) the mixture was hydrogenated in a Parr apparatus at 3 bar H 2 for 24 h. The catalyst was filtered off and the solvent was removed in vacuum. The crude material was purified by flash chromatography (SiO 2 , n-hexane/ EtOAc 1:1). Compound 9 (480 mg, 96%) was obtained as a colourless solid. MP: 132°C. 1 
Marchantin C (5):
To a solution of the dimethylether 9 (523 mg, 1.16 mmol) in anhydrous CH 2 Cl 2 , (80 mL) BBr 3 (1 M in CH 2 Cl 2 , 9.28 mL, 9.82 mmol) was added dropwise at -78°C and the mixture was allowed to warm to r.t. over night. After slow addition of ice-cold water (50 mL), the layers were separated and the aqueous phase was extracted with EtOAc (2 × 50 mL). The combined organic layers were washed with satd NaCl (3 × 100 mL), dried (MgSO 4 ) and the solvent was evaporated in vacuum. Purification of the crude product by flash chromatography (SiO 2 , nhexane/EtOAc 4:1) gives marchantin C (5) (420 mg, 85%) as a colourless solid. MP: 165°C. NMR data see Table 1 
4-(Benzyloxy)-3-hydroxybenzaldehyde (26):
3,4-Dihydroxybenzaldehyde (25) (12.5 g, 90.7 mmol) was dissolved in acetone (100 mL) and after addition of K 2 CO 3 (12.5 g, 90.6 mmol) and benzylbromide (15.4 g, 90.6 mmol), the mixture was stirred for 72 h at 50°C. After cooling to r.t. the reaction mixture was filtered and the solvent was removed in vacuum. Purification of the crude material by column chromatography (SiO 2 , n-hexane/ EtOAc 9:1 → 7:3) yields the monobenzyl ether 26 (11.6 g, 58 %) as a colourless solid. MP: 120°C. 1 
4-(2-(Benzyloxy)-5-(1,3-dioxan-2-yl)phenoxy)benzaldehyde (29):
To a stirred solution of the phenol 27 (14.5 g, 50.7 mmol) in anhydrous DMF (90 mL), 4fluorbenzaldehyde (28) (6.24 mL, 57.8 mmol) and K 2 CO 3 (7.17 g, 51.9 mmol) were added. The resulting mixture was heated to 165°C for 48 h, then poured into ice water and extracted with Et 2 O (3 × 150 mL). The combined organic phases were washed with satd NaCl (5 × 100 mL), dried (MgSO 4 ) and the solvent was distilled off. The crude product was purified by column chromatography (SiO 2 , CH 2 Cl 2 ) to obtain the biarylether 29 (19.6 g, 99%) as a colourless solid. MP: 87°C. 1 (4-(2-(Benzyloxy)-5-(1,3-dioxan-2-yl) 
Phosphonium salt 31:
The benzyl alcohol 30 (15.2 g, 38.6 mmol) and PPh 3 •HBr (14.0 g, 40.7 mmol) were dissolved in MeCN (150 mL) and the reaction mixture was refluxed for 12 h. After concentration of the reaction solution in vacuum, the residue was diluted with CHCl 3 (100 mL) and treated with 1,3-propanediol (27.8 g, 0.37 mol), triethyl orthoformate (20.9 g, 0.11 mol) and tetrabutyl-ammonium tribromide (280 mg, 0.58 mmol). The resulting mixture was refluxed for 12 h. Evaporation of the solvent gives the phosphonium salt 31 (57.3 g, 0.67 mmol/g) contaminated with 1,3-propanediol as a yellow oil. This crude material was used in the following Wittig reaction without further purification steps.
(E)-2-(4-(2-(Benzyloxy)-5-(1,3-dioxan-2-yl)phenoxy)styryl)-6-methoxyphenol (32):
To a solution of the phosphonium salt 31 (contaminated with 1,3-propanediol, 0.67 mmol 31/g) (56.1 g, 37.6 mmol) in anhydrous CH 2 Cl 2 (500 mL) o-vanillin (15) (7.46 g, 49.1 mmol), K 2 CO 3 (15.7 g, 113.7 mmol) and a catalytic amount of 18-crown-6 were added. The resulting mixture was refluxed for 24 h. After cooling to r.t. the reaction mixture was filtered through a thin pad of SiO 2 eluting with CH 2 Cl 2 . After removal of the solvent, the crude product was purified by flash chromatography (SiO 2 , n-hexane/EtOAc 4:1 → 7:3) to give the stilbene 32 (12.6 g, 71%) as a colourless solid. MP: 157°C. 1 
(E)-4-(Benzyloxy)-3-(4-(2-(3-formylphenoxy)-3methoxystyryl)phenoxy)benzaldehyde (33):
To a solution of the phenol 32 (4.80 g, 9.40 mmol) in anhydrous pyridine (100 mL), K 2 CO 3 (5.19 g, 37.6 mmol), CuO (4.04 g, 28.2 mmol) and 3-bromo benzaldehyde (21) (3.30 mL, 28.2 mmol) were added. The resulting mixture was heated to 160°C for 12 h and the solvent was removed under reduced pressure. After dilution with EtOAc the residue was filtered through a thin pad of SiO 2 eluting with EtOAc and the solvent was distilled off. The crude product was dissolved in THF (100 mL) and 2 M HCl (100 mL) and stirred at r.t. for 12 h. The mixture was extracted with Et 2 O (3 × 150 mL), the combined ethereal layers were washed with satd NaHCO 3 and dried (MgSO 4 ). After removing the solvent in vacuum the crude product was purified by flash chromatography (SiO 2 , n-hexane/EtOAc 3:2) to give dialdehyde 39 (3. 
(E/E)-Bis(stilbene) 34:
Macrocycle 34 was prepared from 33 (2.70 g, 4.85 mmol) analogously to the procedure for the synthesis of 24. The crude product, less soluble in most solvents, was crystallized by addition of EtOAc and was obtained as a colourless solid (1.91 g, 75%). MP: 255°C. 1 Marchantin O (7): The stilbene 34 (2.55 g, 4.86 mmol) was dissolved in CHCl 3 (300 mL). After addition of Pd/C (5%) (500 mg) the mixture was hydrogenated in a Parr apparatus at 3 bar H 2 for 72 h. The catalyst was filtered off and the solvent was removed in vacuum. The crude material was purified by flash chromatography (SiO 2 , n-hexane/EtOAc 7:3). Marchantin O (7) (2.13 g, 95%) was obtained as a colourless oil. NMR data see Table 1 
3-(Benzyloxy)-2-hydroxybenzaldehyde (36):
2,3-Dihydroxy benzaldehyde (35) (14.0 g, 0.10 mol) was dissolved in anhydrous THF (250 mL) and NaH (6.08 g, 0.25 mol) was added in small portions at 0°C. After stirring at r.t. for 1 h, BnBr (12.0 mL, 0.10 mol) in THF (50 mL) was added dropwise and stirring was continued for 48 h. The reaction mixture was hydrolyzed carefully with H 2 O and extracted with CHCl 3 (2 × 150 mL). The aqueous layer was acidified to pH 2 with 2 M HCl and extracted once more with CHCl 3 (150 mL). The combined organic layers were washed with satd NaCl, dried (MgSO 4 ) and the solvent was evaporated. Flash chromatography (SiO 2 , CH 2 Cl 2 /n-hexane 8:2 → 9:1) affords 36 (13.5 g, 58%) as a yellow solid. MP: 81°C. 1 
(E/Z)-2-(4-(5-(1,3-Dioxan-2-yl)-2-methoxyphenoxy)styryl)-6-(benzyloxy)phenol (38):
To a solution of the phosphonium salt 37 (contaminated with 1,3-propanediol, 0.72 mmol 37/g) (30.6 g, 22.0 mmol) in anhydrous CH 2 Cl 2 (300 mL) was added K 2 CO 3 (9.12 g, 66.0 mmol), the aldehyde 36 (6.53 g, 28.6 mmol) and a catalytic amount of 18-crown-6. The reaction mixture was heated under reflux for 24 h. After cooling down to r.t., the mixture was filtered through a thin pad of SiO 2 , eluting with n-hexane/EtOAc 1:1 and the solvent was removed in vacuum. The crude product was purified by flash chromatography (SiO 2 , n-hexane/ EtOAc 3:2) to give 39 (E/Z-mixture 70:30, 7.06 g, 63%) as a colourless resin. 
Marchantin P (8):
The stilbene 40 (15.1 mg, 28.8 µmol) was dissolved in CHCl 3 (40 mL). After addition of Pd/C (5%) (20 mg) the mixture was hydrogenated in a Parr compact laboratory autoclave at 20 bar H 2 for 96 h. The catalyst was filtered off and the solvent was removed in vacuum. The crude material was purified by flash chromatography (SiO 2 , n-hexane/EtOAc 1:1). Compound 8 (12.1 mg, 96%) was obtained as a colourless solid. MP: 62°C. NMR data see Table 1 
